IP Library Granted Patent US 7,288,407
Granted Patent B2
US 7,288,407 · App. 10/513,302 · Granted Oct 30, 2007

Stable cytochrome P450 24 (CYP24) expressing cell line and methods and uses thereof

Assignee: Cytochroma, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,288,407
App. No.
10/513,302
Granted
Oct 30, 2007
Kind
B2
Abstract

The invention relates to a stable recombinant host cell comprising a CYP24 nucleic acid. The host cell is preferably a mammalian cell or an insect cell. The cell is useful for identifying modulators of CYP24 that can be used in the treatment of CYP24 expression-related medical conditions.

Claims (10)

1. A cell line that stably expresses an active CYP24 polypeptide, comprising a recombinant CYP24 nucleic acid molecule that is operably linked to a promoter to enable expression thereof, wherein the recombinant CYP24 nucleic acid molecule comprises a nucleic acid having at least 98% identity to SEQ ID NO: 1 that encodes the active CYP24 polypeptide that catalyzes hydroxylation of Vitamin D metabolites.

2. The cell line of claim 1 , wherein the cell is a mammalian cell or an insect cell.

3. The cell line of claim 1 , wherein the cell line expresses adrenodoxin (ADX) and adrenodoxin reductase (ADR).

4. The cell line of claim 1 , wherein the cell is a V79 cell or a Sf9 cell.

5. The cell line of claim 1 , wherein the CYP24 nucleic acid is HPK-1A ras cell CYP24 as shown in SEQ ID NO: 1.

6. The cell line of claim 1 wherein the recombinant CYP24 nucleic acid molecule is in a vector comprising the CYP24 nucleic acid molecule.

7. The cell line of claim 6 wherein the vector is pFastBac1, pcDNA3.1 or pcDNA3.1-Hygro(+).

8. A cell culture that stably expresses CYP24 polypeptide comprising cells of the cell line of claim 1 .

9. A cell culture comprising cells that stably express active CYP24 polypeptide, the cells comprising a recombinant CYP24 nucleic acid molecule that is operably linked to a promoter to enable expression thereof, in a medium capable of sustaining growth and replication of the cells, wherein the recombinant CYP24 nucleic acid molecule comprises a nucleic acid having at least 98% identity to SEQ ID NO: 1 that encodes the active CYP24 polypeptide that catalyzes hydroxylation of Vitamin D metabolites.

10. The cell culture of claim 9 , wherein the cells further comprise an antibiotic resistance gene and the cell culture includes an antibiotic encoded by the antibiotic resistance gene.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2021
From: OPKO IRELAND GLOBAL HOLDINGS, LTD.
To: EIRGEN PHARMA LTD.
Reel/Frame 055765/0953 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 31, 2015
From: CYTOCHROMA CAYMAN ISLANDS LTD.
To: OPKO IP HOLDINGS II, INC.
Reel/Frame 036224/0163 →
CONFIRMATORY PATENT RIGHTS AGREEMENT Recorded Jul 31, 2015
From: OPKO IP HOLDINGS II, INC.
To: OPKO IRELAND GLOBAL HOLDINGS, LTD.
Reel/Frame 036238/0486 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 31, 2015
From: CYTOCHROMA INC.
To: CYTOCHROMA CAYMAN ISLANDS LTD.
Reel/Frame 036238/0359 →
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2013
From: COMERICA BANK, A TEXAS BANKING ASSOCIATION AND AUTHORIZED FOREIGN BANK UNDER THE BANK ACT (CANADA)
To: CYTOCHROMA INC.
Reel/Frame 029914/0404 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTOCHROMA, INC.; CYTOCHROMA HOLDINGS ULC; PROVENTIV THERAPEUTICS, LLC
Reel/Frame 028881/0338 →
SECURITY AGREEMENT Recorded Aug 16, 2012
From: CYTOCHROMA INC., A CORPORATION EXISTING UNDER THE LAWS OF ONTARIO
To: COMERICA BANK, A TEXAS BANKING ASSOCIATION AND AUTHORIZED FOREIGN BANK UNDER THE BANK ACT (CANADA)
Reel/Frame 028801/0539 →
SECURITY AGREEMENT Recorded Sep 28, 2010
From: CYTOCHROMA INC.; PROVENTIV THERAPEUTICS, LLC; CYTOCHROMA HOLDINGS ULC
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 025051/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2005
From: GAO, MIAN
To: CYTOCHROMA, INC.
Reel/Frame 016849/0498 →
Continuity (2)
Provisional Application 6037680600 · May 2, 2002
Related Publication 20060105417A1 · May 18, 2006